HMD Biomedical
Hsinchu, Taiwan· Est.
Taiwanese medtech firm HMD Biomedical provides patented blood‑glucose monitoring devices and supplies for diabetes care.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Taiwanese medtech firm HMD Biomedical provides patented blood‑glucose monitoring devices and supplies for diabetes care.
Diabetes
Technology Platform
Proprietary enzymatic biosensor technology combined with low‑volume test strips and pain‑free lancets, integrated into handheld meters and connected health devices.
Opportunities
Expansion of connected glucose monitoring platforms and entry into emerging markets, as well as diversification into broader metabolic testing solutions.
Risk Factors
Intense competition from global diagnostic giants and regulatory challenges in new regions could limit market penetration.
Competitive Landscape
Competes with Abbott, Roche, Dexcom, and other BGMS manufacturers; differentiates through patented low‑pain lancets, low‑volume testing, and early MDSAP certification.